LYTTON LAURENCE W 13D/13G Filings for DiaMedica Therapeutics Inc. (DMAC)

LYTTON LAURENCE W 13D and 13G filings for DiaMedica Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-15
2:25 pm
Sale
2021-12-31 13G DiaMedica Therapeutics Inc.
DMAC
LYTTON LAURENCE W 1,071,970
4.100%
-308,296decrease
(-22.34%)
Filing
2021-10-06
4:19 pm
Purchase
2021-09-26 13G DiaMedica Therapeutics Inc.
DMAC
LYTTON LAURENCE W 1,380,266
5.200%
1,380,266increase
(New Position)
Filing